Who invested in NeRRe Therapeutics?
NeRRe Therapeutics's investors include U.S. Venture Partners, OrbiMed, Novo Holdings, Forbion Capital Partners and Fountain Healthcare Partners.

United Kingdom · Series B startup
Funding summaryUpdated 26 Oct 2026
$74Mraised across 3 rounds since 2012, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
NeRRe Therapeutics's investors include U.S. Venture Partners, OrbiMed, Novo Holdings, Forbion Capital Partners and Fountain Healthcare Partners.
NeRRe Therapeutics has raised $74M across 3 rounds since 2012.
NeRRe Therapeutics's most recent round was a Series B of $28M in Jul 2021.
NeRRe Therapeutics's largest round on record is $28M (Series B), in Jan 2016.
NeRRe Therapeutics's first round on record, in Jan 2016, was backed by Fountain Healthcare Partners.
NeRRe Therapeutics's latest named round is a Series B, in Jul 2021.
NeRRe Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.